or Try an Advanced Search...

    C1 Inhibitor Stocks List

    Symbol Grade Name % Change
    KALV D KalVista Pharmaceuticals, Inc. -2.01
    PHAR F Pharming Group N.V. -3.23
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Angioedema Complement Deficiency Hereditary Angioedema Pharmaceutical Acute Kidney Injury Biology Biopharmaceutical Products Complement System Diabetic Macular Edema Disease Drug Discovery Enzymes Eye Haemophilia Kallikrein Life Sciences Macular Edema Organ Systems Pharming Plasma Kallikrein

    Related ETFs - A few ETFs which own one or more of the above listed C1 Inhibitor stocks.

    Symbol Grade Name Weight
    BTEC D Principal Healthcare Innovators Index ETF 0.14
    IWC C iShares Microcap ETF 0.09
    IBBQ C Invesco Nasdaq Biotechnology ETF 0.05
    BIB D ProShares Ultra Nasdaq Biotechnology 0.04
    AVSC C Avantis U.S. Small Cap Equity ETF 0.04
    View all C1 Inhibitor ETFs...
    Compare ETFs
    Compare BTEC to AVSC Compare BTEC to BIB Compare IWC to BIB

        C1 Inhibitor Stocks Recent News

        Date Stock Title
        Apr 22 KALV KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors
        Apr 22 PHAR Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
        Apr 19 PHAR Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
        Apr 18 PHAR Pharming Group announces the placement of €100 million convertible bonds due 2029
        Apr 18 PHAR Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
        Related Industries: Biotechnology
        Related Stock Lists: Angioedema Complement Deficiency Hereditary Angioedema Pharmaceutical Acute Kidney Injury Biology Biopharmaceutical Products Complement System Diabetic Macular Edema Disease Drug Discovery Enzymes Eye Haemophilia Kallikrein Life Sciences Macular Edema Organ Systems Pharming Plasma Kallikrein
        C1 Inhibitor

        C1 Inhibitor is a protein that helps regulate the activity of the complement system, which is part of the body's immune system. It helps to control inflammation and prevent the body from attacking itself. C1 Inhibitor is also used to treat certain types of hereditary angioedema, a condition that causes swelling in the face, throat, and other parts of the body.

        Browse All Tags